Research Insights
Tobacco Use and HIV in Low and Middle-Income Countries (U01 Clinical Trial Optional)
This FOA supports the development and evaluation of tobacco cessation interventions tailored to HIV-positive populations, including those with comorbidities such as tuberculosis (TB), in low-resource settings in low- and middle-income countries.
FON: RFA-CA-20-037
Agency: NIH
Link: https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-20-037.html
Amount: $2,500,000
Due date: Sept 24, 2020
Brief Description: This FOA supports the development and evaluation of tobacco cessation interventions tailored to HIV-positive populations, including those with comorbidities such as tuberculosis (TB), in low-resource settings in low- and middle-income countries (LMICs). In particular, this FOA aims to bring together transdisciplinary teams of investigators to adapt interventions developed and tested in other challenging settings or low-resource populations and to test their robustness among persons living with HIV (PLWH) in LMICs.